point-of-care diagnostic tests

Abbott to acquire Alere for $5.8 billion

Abbott said that it has signed a definitive deal to acquire Alere for a net value of $5.8 billion in cash. Abbott expects the acquisition to be immediately accretive to its earnings per share upon completion.

Read Full Article

California-based Nanomix nabs $12M in financing

Nanomix Inc, a California-based nanotechnology firm that develops next generation point-of-care diagnostic tests, received $12 million in private funding from "a strategic corporate partner and existing investors."

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics